CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease 2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization) A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF) Outcomes of patients with and without baseline lipid-lowering therapy undergoing revascularization for left main coronary artery disease: analysis from the EXCEL trial SPECT and PET in ischemic heart failure 2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques Colchicine Reduces Cardiovascular Events in Chronic Coronary Disease Therapeutic efficacy of paclitaxel-coated balloon for de novo coronary lesions with diameters larger than 2.8 mm

Original Research2006 Mar 23;354(12):1264-72.

JOURNAL:N Engl J Med. Article Link

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

Cohen JC, Boerwinkle E, Mosley TH Jr et al. Keywords: PCSK9; Low LDL; CHD

FULL TEXT PDF